Q2 FY2026 EarningsQ2 FY26 results missed consensus on the top and operating lines, with revenue of $2.18M (-9.2% vs. consensus) and gross margin of 35.1% (-6.9pct vs. consensus). Despite the operating miss, the bottom line reported a GAAP net income of $0.89M, significantly beating the expected loss of $1.43M, driven primarily by a $2.45M one-time non-cash gain from the remeasurement of the Alabama JV acquisition. Management secured a critical $15M-$50M equity financing facility (AMPA) post-quarter to address persistent going concern risks and fund a robust acquisition pipeline.
Overview: INVO Fertility(IVF) the Revenue is 2.175 M (+16.73%), Miss estimate;the EBIT is -1.29 M (+56.87%), Miss estimate;the EPS is 0.35 (--%), Beat estimate.